Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women

被引:1
|
作者
Skvortsova, Liliya [1 ]
Abdikerim, Saltanat [1 ,2 ]
Yergali, Kanagat [1 ]
Mit, Natalya [1 ]
Perfilyeva, Anastassiya [1 ]
Omarbayeva, Nazgul [3 ,4 ]
Zhunussova, Aigul [1 ]
Kachiyeva, Zulfiya [5 ]
Sadykova, Tolkyn [3 ,4 ]
Bekmanov, Bakhytzhan [1 ,2 ]
Kaidarova, Dilyara [3 ,4 ]
Djansugurova, Leyla [1 ,2 ]
Zhunussova, Gulnur [1 ]
机构
[1] Inst Genet & Physiol, Lab Mol Genet, Alma Ata 050060, Kazakhstan
[2] Al Farabi Kazakh Natl Univ, Dept Mol Biol & Genet, Alma Ata 050040, Kazakhstan
[3] Kazakh Inst Oncol & Radiol, Breast Canc Dept, Alma Ata 050060, Kazakhstan
[4] Asfendiyarov Kazakh Natl Med Univ, Oncol Dept, Alma Ata 050012, Kazakhstan
[5] Asfendiyarov Kazakh Natl Med Univ, Res Inst Appl & Fundamental Med, Alma Ata 050012, Kazakhstan
关键词
early-onset breast cancer; microarray-based SNP genotyping; genome-wide association study; genetic variations; genetic markers; Kazakh population; CHITINASE; YKL-39; GROWTH; ALPHA-2-MACROGLOBULIN; EXPRESSION; CELLS;
D O I
10.3390/genes15010108
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Breast cancer is a global health problem. It is an age-dependent disease, but cases of early-onset breast cancer (eBC) are gradually increasing. There are many unresolved questions regarding eBC risk factors, mechanisms of development and screening. Only 10% of eBC cases are due to mutations in the BRCA1/BRCA2 genes, and 90% have a more complex genetic background. This poses a significant challenge to timely cancer detection in young women and highlights the need for research and awareness. Therefore, identifying genetic risk factors for eBC is essential to solving these problems. This study represents an association analysis of 144 eBC cases and 163 control participants to identify genetic markers associated with eBC risks in Kazakh women. We performed a two-stage approach in association analysis to assess genetic predisposition to eBC. First-stage genome-wide association analysis revealed two risk intronic loci in the CHI3L2 gene (p = 5.2 x 10(-6)) and MGAT5 gene (p = 8.4 x 10(-6)). Second-stage exonic polymorphisms haplotype analysis showed significant risks for seven haplotypes (p < 9.4 x 10(-4)). These results point to the importance of studying medium- and low-penetrant genetic markers in their haplotype combinations for a detailed understanding of the role of detected genetic markers in eBC development and prediction.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Familial association of laryngeal, lung, stomach and early-onset breast cancer
    Ewa Jaworowska
    Pablo Serrano-Fernández
    Czesława Tarnowska
    Jakub Lubiński
    Marek Brzosko
    Jacek Flicinski
    Bartołomej Masojc
    Joanna Matyjasik
    Rodney J. Scott
    Steven A. Narod
    Jan Lubiński
    Breast Cancer Research and Treatment, 2008, 112 : 359 - 361
  • [22] GENETIC-HETEROGENEITY OF EARLY-ONSET FAMILIAL BREAST-CANCER
    SOBOL, H
    MAZOYER, S
    NAROD, SA
    SMITH, SA
    BLACK, DM
    KERBRAT, P
    JAMOT, B
    SOLOMON, E
    PONDER, BAJ
    GUERIN, D
    HUMAN GENETICS, 1992, 89 (04) : 381 - 383
  • [23] Genetic and non-genetic risk factors for early-onset pancreatic cancer
    Nodari, Ylenia
    Gentiluomo, Manuel
    Mohelnikova-Duchonova, Beatrice
    Kreivenaite, Edita
    Milanetto, Anna Caterina
    Skieceviciene, Jurgita
    Landi, Stefano
    Lawlor, Rita
    Petrone, Maria Chiara
    Arcidiacono, Paolo Giorgio
    Lovecek, Martin
    Gazouli, Maria
    Bijlsma, Maarten F.
    Morelli, Luca
    Kiudelis, Vytautas
    Tacelli, Matteo
    Zanette, Dalila Luciola
    Kaaks, Pavel Soucek
    Uzunoglu, Faik
    Kaaks, Rudolf
    Izbicki, Jakob
    Boggi, Ugo
    Pezzilli, Raffaele
    Mambrini, Andrea
    Pasquali, Claudio
    van Laarhove, Hanneke W.
    Katzke, Verena
    Cavestro, Giulia Martina
    Sperti, Cosimo
    Loos, Martin
    Latiano, Anna
    Eross, Balint
    Oliverius, Martin
    Johnson, Theron
    Basso, Daniela
    Neoptolemos, John P.
    Aoki, Mateus Nobrega
    Greenhalf, William
    Vodick, Pavel
    Archibugi, Livia
    Vanella, Giuseppe
    Lucchesi, Maurizio
    Talar-Wojnarowska, Renata
    Jamroziak, Krzysztof
    Al Saeedi, Mohammed
    van Eijck, Casper H. J.
    Kupcinskas, Juozas
    Hussein, Tamas
    Puzzono, Marta
    Bunduc, Stefania
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (10) : 1417 - 1425
  • [24] Familial association of laryngeal, lung, stomach and early-onset breast cancer
    Jaworowska, Ewa
    Serrano-Fernandez, Pablo
    Tarnowska, Czeslawa
    Lubinski, Jakub
    Brzosko, Marek
    Flicinski, Jacek
    Masojc, Bartolomej
    Matyjasik, Joanna
    Scott, Rodney J.
    Narod, Steven A.
    Lubinski, Jan
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (02) : 359 - 361
  • [25] Association of FGD1 polymorphisms with early-onset breast cancer
    Beasley, Sarah
    Buckhaults, Phillip J.
    Pedigo, Nancy G.
    Farrell, Christopher L.
    ONCOLOGY LETTERS, 2016, 12 (03) : 2071 - 2077
  • [26] Non-BRCA Early-Onset Breast Cancer in Young Women
    Gao, Yiming
    Samreen, Naziya
    Heller, Samantha L.
    RADIOGRAPHICS, 2022, 42 (01) : 5 - 22
  • [27] Familial aggregation of early-onset cancers in early-onset breast cancer families
    Rantala, Jasmiina N. J.
    Heikkinen, Sanna M.
    Hirvonen, Elli M.
    Tanskanen, Tomas
    Malila, Nea K.
    Pitkaniemi, Janne M.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (02) : 331 - 340
  • [28] Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum
    Burton, K. R.
    Park, A. L.
    Fralick, M.
    Ray, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (05) : 876 - 885
  • [29] Information needs about hereditary breast cancer among women with early-onset breast cancer
    Cohn, WF
    Ropka, ME
    Jones, SM
    Miesfeldt, S
    CANCER DETECTION AND PREVENTION, 2003, 27 (05): : 345 - 352
  • [30] Cancer risk in close relatives of women with early-onset breast cancer – a population-based incidence study
    J H Olsen
    N Seersholm
    J D Boice
    S Krüger Kjær
    J F Fraumeni
    British Journal of Cancer, 1999, 79 : 673 - 679